Status and phase
Conditions
Treatments
About
Several nasal dilators are currently commercially available, and can be applied endonasally (Airmax°, Nozovent and Nasanita°) or externally (Breath Right°). An objective comparison between these dilators has not been made so far, and would help the clinicians to advise the use of any of these dilators. From clinical experience, endonasal dilators are well supported and improve breathing better than the external dilators
Full description
Several nasal dilators are currently commercially available, and can be applied endonasally (Airmax°, Nozovent and Nasanita°) or externally (Breath Right°). An objective comparison between these dilators has not been made so far,
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Patients with nasal obstruction due to external nasal valve problems and with positive Cottle sign.
Age > 18 and < 60 years. Ability to give reliable information and written informed consent.
Exclusion criteria
Patients with nasal obstruction due to other endonasal anatomic deformities besides external nasal valve dysfunction.
Patients with rhinosinusitis and/or nasal polyps evaluated by nasal endoscopy. Patients with chronic lower airway disease like severe asthma, chronic obstructive pulmonary disease (COPD), bronchiectasis and/or other conditions that interfere with the generation of a reliable Peak Nasal Inspiratory Flow (PNIF) result.
Primary purpose
Allocation
Interventional model
Masking
100 participants in 4 patient groups
Loading...
Central trial contact
Peter Hellings, Prof Dr
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal